[−2 ] PRO-PSA IS MORE ACCURATE THAN TOTAL AND FREE PSA IN DIFFERENTIATING PROSTATE CANCER FROM BENIGN DISEASE IN A PROSPECTIVE PROSTATE CANCER SCREENING STUDY,

PURPOSE: Due to the limited specificity of prostate-specific antigen (PSA) for prostate cancer (CaP) screening, there is an ongoing search for adjunctive biomarkers. Retrospective studies have suggested that an isoform of proenzyme PSA called [−2] proPSA (p2PSA) may enhance the specificity of PSA-ba...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Le, Brian V., Griffin, Christopher R., Loeb, Stacy, Carvalhal, Gustavo F., Kan, Donghui, Baumann, Nikola A., Catalona, William J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537165/
https://ncbi.nlm.nih.gov/pubmed/20171670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.12.056
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller